David Manuel
Castro Díaz
Investigador en el periodo 1990-2024
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (6)
2024
2022
-
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 4
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 13
2021
-
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
Scientific Reports, Vol. 11, Núm. 1
2018
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
BJU International, Vol. 122, Núm. 6, pp. 1049-1065
2014
-
Bladder cancer index: Cross-cultural adaptation into Spanish and psychometric evaluation
Health and Quality of Life Outcomes, Vol. 12, Núm. 1